Position in TERN
as of Mar 31, 2026
· filed Apr 9, 2026
Position Value
$0
New position
Shares Held
26
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Park Place Capital Corp holds $841,864 across 23 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
676 | $335,789 | |
| 2 | RPRX |
Royalty Pharma plc
|
3,510 | $196,805 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
328 | $98,737 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
1,433 | $81,996 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
594 | $46,492 | |
| 6 | TECH |
BIO-TECHNE Corp
|
468 | $33,064 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
94 | $22,651 | |
| 8 | ARGX |
Argenx SE
|
6 | $5,566 |
All Filings in TERN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 26 | Shares | Sole | 2026-04-09 | |
| No filing history on record for this holder in this stock. | ||||||